ES2313063T3 - Procedimientos de radiomarcado con carbono 11 de compuestos fenotiazinicos y de tipo fenotiazinico. - Google Patents

Procedimientos de radiomarcado con carbono 11 de compuestos fenotiazinicos y de tipo fenotiazinico. Download PDF

Info

Publication number
ES2313063T3
ES2313063T3 ES04768696T ES04768696T ES2313063T3 ES 2313063 T3 ES2313063 T3 ES 2313063T3 ES 04768696 T ES04768696 T ES 04768696T ES 04768696 T ES04768696 T ES 04768696T ES 2313063 T3 ES2313063 T3 ES 2313063T3
Authority
ES
Spain
Prior art keywords
phenothiazine
ring
group
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04768696T
Other languages
English (en)
Spanish (es)
Inventor
Lutz F. c/o University of Aberdeen SCHWEIGER
Stuart A. c/o University of Aberdeen CRAIB
Andrew E. c/o University of Aberdeen WELCH
Peter F. c/o University of Aberdeen SHARP
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Aberdeen filed Critical University of Aberdeen
Application granted granted Critical
Publication of ES2313063T3 publication Critical patent/ES2313063T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Catalysts (AREA)
ES04768696T 2003-09-29 2004-09-27 Procedimientos de radiomarcado con carbono 11 de compuestos fenotiazinicos y de tipo fenotiazinico. Expired - Lifetime ES2313063T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0322756.8A GB0322756D0 (en) 2003-09-29 2003-09-29 Methods of chemical synthesis
GB0322756 2003-09-29

Publications (1)

Publication Number Publication Date
ES2313063T3 true ES2313063T3 (es) 2009-03-01

Family

ID=29287034

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04768696T Expired - Lifetime ES2313063T3 (es) 2003-09-29 2004-09-27 Procedimientos de radiomarcado con carbono 11 de compuestos fenotiazinicos y de tipo fenotiazinico.

Country Status (13)

Country Link
US (1) US20060275209A1 (https=)
EP (1) EP1667947B1 (https=)
JP (1) JP2007508282A (https=)
CN (2) CN101172162A (https=)
AT (1) ATE405533T1 (https=)
AU (1) AU2004276071B2 (https=)
CA (1) CA2540827A1 (https=)
DE (1) DE602004016010D1 (https=)
ES (1) ES2313063T3 (https=)
GB (1) GB0322756D0 (https=)
PL (1) PL1667947T3 (https=)
SI (1) SI1667947T1 (https=)
WO (1) WO2005030676A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
GB0100119D0 (en) 2001-01-03 2001-02-14 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0101049D0 (en) 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0106953D0 (en) 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
GB0117326D0 (en) 2001-07-16 2001-09-05 Univ Aberdeen Napthoquinone-type inhibitors of protein aggregation
CN101084204B (zh) 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
MY162640A (en) 2006-03-29 2017-06-30 Wista Lab Ltd Thioninium compounds and their use
PL2004155T3 (pl) 2006-03-29 2018-08-31 Wista Laboratories Ltd. Inhibitory agregacji białek
EP2013191B3 (en) 2006-03-29 2019-02-27 Wista Laboratories Ltd. 3,7-diamino-10h-phenothiazine salts and their use
DK3121169T3 (da) 2006-07-11 2022-02-28 Wista Lab Ltd Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
CA3027974C (en) 2007-10-03 2022-03-15 Wista Laboratories Ltd. Therapeutic use of diaminophenothiazines
DK3378856T3 (da) 2009-09-24 2020-12-21 Wista Lab Ltd Krystallinske methylthioniniumchlorid-hydrater
US9192611B2 (en) 2010-11-30 2015-11-24 Wista Laboratories Ltd. Formulations comprising methylthioninium chloride
EA025033B1 (ru) 2011-02-11 2016-11-30 Уиста Лэборэтэриз Лтд. Диаминиевые соли фенотиазина и их применение
US20130315825A1 (en) * 2012-05-03 2013-11-28 Washington University Tricyclic heteroaromatic compounds as alpha-synuclein ligands
US11001562B2 (en) 2013-10-31 2021-05-11 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
US11077210B2 (en) * 2013-10-31 2021-08-03 Beth Israel Deaconess Medical Center Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
GB201512678D0 (en) 2015-07-20 2015-08-26 Wista Lab Ltd Methods of chemical synthesis
CN109796465B (zh) * 2017-11-16 2020-07-14 华中科技大学同济医学院附属协和医院 靶向pet显像化合物、包含该化合物的显象剂及其制备方法和用途
US20210011008A1 (en) * 2019-07-09 2021-01-14 Vanderbilt University Amyloid-binding compounds and methods of use thereof
CN115304633B (zh) * 2022-07-20 2023-12-26 山西大学 一种无重原子光动力光敏剂及其制备方法和应用
US12440585B2 (en) 2023-09-12 2025-10-14 Curadel Surgical Innovations, Inc. Zwitterionic metal chelators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000344685A (ja) * 1999-03-26 2000-12-12 Bf Kenkyusho:Kk アズールａ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物
JP4275819B2 (ja) * 1999-09-17 2009-06-10 飯田 秀博 デメチルラクロプライドの非求核性酸塩およびこれを用いる［ｃ−１１］ラクロプライドの製造法
GB0106953D0 (en) * 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers

Also Published As

Publication number Publication date
SI1667947T1 (sl) 2009-02-28
DE602004016010D1 (de) 2008-10-02
EP1667947A1 (en) 2006-06-14
CN101172162A (zh) 2008-05-07
AU2004276071A1 (en) 2005-04-07
AU2004276071B2 (en) 2011-02-03
CN1886353B (zh) 2010-06-02
ATE405533T1 (de) 2008-09-15
PL1667947T3 (pl) 2009-01-30
GB0322756D0 (en) 2003-10-29
HK1087394A1 (en) 2006-10-13
EP1667947B1 (en) 2008-08-20
JP2007508282A (ja) 2007-04-05
WO2005030676A1 (en) 2005-04-07
CA2540827A1 (en) 2005-04-07
CN1886353A (zh) 2006-12-27
US20060275209A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
ES2313063T3 (es) Procedimientos de radiomarcado con carbono 11 de compuestos fenotiazinicos y de tipo fenotiazinico.
ES2689029T3 (es) Hidratos de cloruro de metiltioninio cristalinos - Parte 2
US20250375542A1 (en) 18f-labeled psma-targeted pet imaging agents
ES2620402T3 (es) Sintesis de estirilpiridinas radiomarcadas con 18F a partir de precursores de tosilato y composiciones farmacéuticas estables de las mismas
ES2409683T3 (es) Procedimientos de síntesis química y purificación de compuestos de diaminofenotiazinio que incluyen cloruro de metiltioninio (CMT)
ES2529714T3 (es) Procedimientos de síntesis y/o de purificación de compuestos de diaminofenotiazinio
ES2913469T3 (es) Métodos para tratar la depresión usando antagonistas del receptor de orexina-2
ES2659030T3 (es) Compuestos de tioninio y su uso
CN101678129B (zh) 用于ccr5体内成像的放射性pet试剂
ES2553628T3 (es) Compuestos como moduladores de una proteína CFTR mutante y su uso para el tratamiento de enfermedades asociadas con el mal funcionamiento de la proteína CFTR
ES2642086T5 (es) Procedimiento para la producción de ligandos de beta amiloide marcados con F-18
ES2451642T3 (es) Derivados de indol tetracíclicos como agentes de formación de imágenes in vivo y que tienen afinidad por receptores de benzodiazepina periféricos (PBR)
AU2004294784A1 (en) Novel imaging agents comprising caspase-3 inhibitors
BR112019011486A2 (pt) síntese de um ácido tiossulfônico através de uma etapa de acoplamento oxidativo mediado por periodato de um ácido tiossulfônico com uma anilina
US9517279B2 (en) 2-alkoxy-11-hydroxyaporphine derivatives and uses thereof
HK1087394B (en) Methods of 11c -radiolabelling phenothiazine and pheno thiazine-like compounds
AU2003273505A1 (en) Improved imaging agents comprising barbituric acid derivatives
ES2371927T3 (es) Compuestos de bencil-lactama marcados con 11c y su uso como agentes de obtención de imágenes.
WO2009001046A2 (en) [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use
WO2025155818A1 (en) Fibroblast activation protein-targeted radioligands with pharmacokinetic modulators
CN102202503A (zh) 放射性碘化苯甲酰胺衍生物的药用组合物及其制备方法